Morgan Stanley’s Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share BOXD.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,070
Closed -$42 7910
2022
Q4
$42 Hold
1,070
﹤0.01% 7741
2022
Q3
$0 Hold
1,070
﹤0.01% 8047
2022
Q2
$0 Hold
1,070
﹤0.01% 8142
2022
Q1
$1K Hold
1,070
﹤0.01% 7913
2021
Q4
$1K Buy
+1,070
New +$972 ﹤0.01% 7924

Other funds holding BOXD.WS

Morgan Stanley's BOXD.WS Position: Q1 2023 in Review

Morgan Stanley sold out of Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share (BOXD.WS) in Q1 2023, closing a stake of 1,070 shares — an estimated $42 sold.

Morgan Stanley first reported a position in BOXD.WS in Q4 2021 and held it in 5 quarters. The position peaked at $1K in Q1 2022. 7 funds tracked by Wall St. Rank hold BOXD.WS as of Q1 2023.

  • Morgan Stanley reported no remaining Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share position as of Q1 2023 after selling out during the quarter.
  • Morgan Stanley sold 1,070 Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share shares in Q1 2023, an estimated $42.
  • Morgan Stanley first reported a position in Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 5 quarters.
  • Morgan Stanley's Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share position peaked at $1K in Q1 2022.
  • 7 funds tracked by Wall St. Rank held Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share as of Q1 2023.

Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.